度洛西汀治疗重性抑郁障碍有效性与安全性的Meta分析(5)
[19] BOULENGER JP，LOFT H，OLSEN CK. Efficacy and safety of vortioxetine(Lu AA21004)，15 and 20 mg/day：a randomized，double-blind，placebo-controlled，duloxetine- referenced study in the acute treatment of adult patients with major depressive disorder[J]. Int Clin Psychopharmacol，2014，29(3)：138-149.
[20] MAHABLESHWARKAR AR，JACOBSEN PL，CHEN Y，et al. A randomized，double-blind，duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD[J]. Psychopharmacology：Berl，2015，232(12)：2061- 2070.
[21] MAHABLESHWARKAR AR，ZAJECKA J，JACOBSON W，et al. A randomized，placebo-controlled，active-refe- rence，double-blind，flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder[J]. Neuropsychopharmacology，2015，40(8)：2025- 2037.
[22] WANG L，AN J，GAO HM，et al. Duloxetine effects on striatal resting-state functional connectivity in patients with major depressive disorder[J]. Hum Brain Mapp，2019，40(11)：3338-3346.
(收稿日期：2019-05-28 修回日期：2019-10-21)
(編辑：陈 宏), 百拇医药(刁云 杨航 舒云峰 杜彪)
[20] MAHABLESHWARKAR AR，JACOBSEN PL，CHEN Y，et al. A randomized，double-blind，duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD[J]. Psychopharmacology：Berl，2015，232(12)：2061- 2070.
[21] MAHABLESHWARKAR AR，ZAJECKA J，JACOBSON W，et al. A randomized，placebo-controlled，active-refe- rence，double-blind，flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder[J]. Neuropsychopharmacology，2015，40(8)：2025- 2037.
[22] WANG L，AN J，GAO HM，et al. Duloxetine effects on striatal resting-state functional connectivity in patients with major depressive disorder[J]. Hum Brain Mapp，2019，40(11)：3338-3346.
(收稿日期：2019-05-28 修回日期：2019-10-21)
(編辑：陈 宏), 百拇医药(刁云 杨航 舒云峰 杜彪)